| 801 |
|
Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin/
|
Bagley, K. C
|
Butterworths
|
2003
|
|
|
|
| 802 |
|
Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration
|
Delmastro, P
|
Butterworths
|
1997
|
|
|
|
| 803 |
|
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users
|
Iorio, A. M
|
Butterworths
|
1997
|
|
|
|
| 804 |
|
Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine/
|
Cedillo-Barron, L
|
Butterworths
|
2003
|
|
|
|
| 805 |
|
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants
|
Le, T. P
|
Butterworths
|
1998
|
|
|
|
| 806 |
|
Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine/
|
Netter, H. J
|
Butterworths
|
2003
|
|
|
|
| 807 |
|
Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine/
|
Confer, A. W
|
Butterworths
|
2003
|
|
|
|
| 808 |
|
Immunogenicity of trivalent subunit versus virosome-formulated influenzavaccines in geriatric patients
|
Conne, P
|
Butterworths
|
1997
|
|
|
|
| 809 |
|
Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine/
|
Jones, Robert L
|
Butterworths
|
2001
|
|
|
|
| 810 |
|
Immunogenicity, safety and protective efficacy of one dose of the rhesusrotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru
|
Lanata, C. F
|
Butterworths
|
1997
|
|
|
|
| 811 |
|
Immunogenic potential of rgp120 from African HIV-1 subtype A
|
Xie, J.-M
|
Butterworths
|
1996
|
|
|
|
| 812 |
|
Immunoglobulin free light chain assay using latex agglutination
|
Wakasugi, K
|
Butterworths
|
1995
|
|
|
|
| 813 |
|
Immunological parameters associated with antigenic competition in a multivalent footrot vaccine
|
Hunt, J. D
|
Butterworths
|
1995
|
|
|
|
| 814 |
|
Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection
|
York, L. J
|
Butterworths
|
1995
|
|
|
|
| 815 |
|
Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands/
|
Eo, Seong Kug
|
Butterworths
|
2001
|
|
|
|
| 816 |
|
Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users
|
Lugoboni, F
|
Butterworths
|
1997
|
|
|
|
| 817 |
|
Immunosuppression and nitric oxide production induced by parenteral liveSalmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect
|
Eisenstein, T. K
|
Butterworths
|
1998
|
|
|
|
| 818 |
|
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine/
|
Santos, W. R
|
Butterworths
|
2003
|
|
|
|
| 819 |
|
Impact of different dietary fatty acids on plasma and liver lipids is influenced by dietary cholesterol in rats
|
Rule, D. C
|
Butterworths
|
1980
|
|
|
|
| 820 |
|
Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine/
|
Melbye, M. Hviid, A.
|
Butterworths
|
2004
|
|
|
|